Role of autologous stem-cell transplantation in multiple myeloma

被引:19
作者
Attal, Michel [2 ]
Harousseau, Jean-Luc [1 ]
机构
[1] Hop Hotel Dieu, Ctr Hosp Univ, F-44093 Nantes 01, France
[2] CHU Purpan, Dept Hematol, F-31059 Toulouse, France
关键词
multiple myeloma; high-dose therapy; autologous stem-cell transplantation; double transplantation; novel agents; thalidomide; bortezomib; lenalidomide; induction; maintenance;
D O I
10.1016/j.beha.2007.09.006
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Multiple myeloma (MM) is one of the diseases in which the impact of dose intensity has been demonstrated. Consequently, in 2005 MM was the first disease for which autologous stem-cell transplantation (ASCT) was indicated in Europe and the US. However, ASCT is not curative, and most patients relapse in a median of 3 years. The introduction of novel agents such as thalidomide, bortezomib (Velcade (R)) or lenalidomide (Revlimid (R)) was logical to try to improve the high-dose strategy, and promising results have been reported. This article will focus on the current results of ASCT and will discuss the main research area to try to improve this strategy.
引用
收藏
页码:747 / 759
页数:13
相关论文
共 55 条
[1]   EARLY MYELOABLATIVE THERAPY FOR MULTIPLE-MYELOMA [J].
ALEXANIAN, R ;
DIMOPOULOS, MA ;
HESTER, J ;
DELASALLE, K ;
CHAMPLIN, R .
BLOOD, 1994, 84 (12) :4278-4282
[2]   Single versus double autologous stem-cell transplantation for multiple myeloma [J].
Attal, M ;
Harousseau, JL ;
Facon, T ;
Guilhot, F ;
Doyen, C ;
Fuzibet, JG ;
Monconduit, M ;
Hulin, C ;
Caillot, D ;
Bouabdallah, R ;
Voillat, L ;
Sotto, JJ ;
Grosbois, B ;
Bataille, R .
NEW ENGLAND JOURNAL OF MEDICINE, 2003, 349 (26) :2495-2502
[3]   A prospective, randomized trial of autologous bone marrow transplantation and chemotherapy in multiple myeloma [J].
Attal, M ;
Harousseau, JL ;
Stoppa, AM ;
Sotto, JJ ;
Fuzibet, JG ;
Rossi, JF ;
Casassus, P ;
Maisonneuve, H ;
Facon, T ;
Ifrah, N ;
Payen, C ;
Bataille, R .
NEW ENGLAND JOURNAL OF MEDICINE, 1996, 335 (02) :91-97
[4]   Maintenance, therapy with thalidomide improves survival in patients with multiple myeloma [J].
Attal, Michel ;
Harousseau, Jean-Luc ;
Leyvraz, Serge ;
Doyen, Chantal ;
Hulin, Cyrille ;
Benboubker, Lofti ;
Agha, Ibrahim Yakoub ;
Bourhis, Jean-Henri ;
Garderet, Laurent ;
Pegourie, Brigitte ;
Dumontet, Charles ;
Renaud, Marc ;
Voillat, Laurent ;
Berthou, Christian ;
Marit, Gerald ;
Monconduit, Mathieu ;
Caillot, Denis ;
Grobois, Bernard ;
Avet-Loiseau, Herve ;
Moreau, Philippe ;
Facon, Thierry .
BLOOD, 2006, 108 (10) :3289-3294
[5]   Prothrombotic coagulation abnormalities in patients with newly diagnosed multiple myeloma [J].
Auwerda, Johannes J. A. ;
Sonneveld, Pieter ;
de Maat, Monica P. M. ;
Leebeek, Frank W. G. .
HAEMATOLOGICA, 2007, 92 (02) :279-280
[6]   Genetic abnormalities and survival in multiple myeloma: the experience of the Intergroupe Francophone du Myelome [J].
Avet-Loiseau, Herve ;
Attal, Michel ;
Moreau, Philippe ;
Charbonnel, Catherine ;
Garban, Frederic ;
Hulin, Cyrille ;
Leyvraz, Serge ;
Michallet, Mauricette ;
Yakoub-Agha, Ibrahim ;
Garderet, Laurent ;
Marit, Gerald ;
Michaux, Lucienne ;
Voillat, Laurent ;
Renaud, Marc ;
Grosbois, Bernard ;
Guillerm, Gaelle ;
Benboubker, Lotfi ;
Monconduit, Mathieu ;
Thieblemont, Catherine ;
Casassus, Philippe ;
Caillot, Denis ;
Stoppa, Anne-Marie ;
Sotto, Jean-Jacques ;
Wetterwald, Marc ;
Dumontet, Charles ;
Fuzibet, Jean-Gabriel ;
Azais, Isabelle ;
Dorvaux, Veronique ;
Zandecki, Marc ;
Bataille, Regis ;
Minvielle, Stephane ;
Harousseau, Jean-Luc ;
Facon, Thierry ;
Mathiot, Claire .
BLOOD, 2007, 109 (08) :3489-3495
[7]   Results of autologous stem cell transplant in multiple myeloma patients with renal failure [J].
Badros, A ;
Barlogie, B ;
Siegel, E ;
Roberts, J ;
Langmaid, C ;
Zangari, M ;
Desikan, R ;
Shaver, MJ ;
Fassas, A ;
McConnell, S ;
Muwalla, F ;
Barri, Y ;
Anaissie, E ;
Munshi, N ;
Tricot, G .
BRITISH JOURNAL OF HAEMATOLOGY, 2001, 114 (04) :822-829
[8]  
BARDROS A, 2001, BRIT J HAEMATOL, V114, P600
[9]   Total therapy 2 without thalidomide in comparison with total therapy 1: role of intensified induction and posttransplantation consolidation therapies [J].
Barlogie, B ;
Tricot, G ;
Rasmussen, E ;
Anaissie, E ;
van Rhee, F ;
Zangari, M ;
Fassas, A ;
Hollmig, K ;
Pineda-Roman, M ;
Shaughnessy, J ;
Epstein, J ;
Crowley, J .
BLOOD, 2006, 107 (07) :2633-2638
[10]  
BARLOGIE B, 1987, BLOOD, V70, P869